New system incorporates artificial intelligence features intended to truncate exam time and create more consistently repeatable exams.
The U.S. Food & Drug Administration, on Oct. 12, awarded GE Healthcare 510(k) clearance for the Ultra Edition package for its Vivid cardiovascular ultrasound system.
Ultra Edition features on this new system, company officials said, can deliver repeatable exam assessments, helping providers identify whether patients have improved or whether their disease is progressing. Vivid Ultra Edition uses the AI Auto Measure-2D feature to increase scanning process efficiencies for reduced exam times with up to 80 percent fewer clicks and 99 percent accuracy by using the View Recognition feature. The AI Auto Measure-2D feature also allows for less inter-operator variability. This advance is critical, they said, because currently capturing heart function assessments is tedious and time-consuming.
Vivid E95 Courtesy: GE Healthcare
According to a company statement, the Vivid Ultra Edition, which is driven by cSound, GE’s unique software-based ultrasound beam-forming platform, includes three neural network-based algorithms driven by artificial intelligence (AI) that can more quickly produce repeatable measurements in 2D echo imaging:
Using this system has already resulted in time-savings for one system user, the company said.
“We use AI Auto Measure-2D, AI Auto Measure-Spectrum Recognition, and Auto AFI together with Auto EF. We also use Scan Assist Pro, 4D biplane and 4D triplane,” said Rebecca Perry, Ph.D., cardiac sonography program stream coordinator at the University of South Australia. “All of this in combination has saved us 7-to-10 minutes per scan, which is fantastic, so we really do have more time to spend with the patient.”
Additionally, said Dagfinn Saetre, general manager of cardiovascular ultrasound at GE, the Vivid Ultra Edition also offers new image quality, advanced visualization, and navigation capabilities:
“With the Vivid Ultra Editions, we offer AI capabilities that hlep address healthcare providers’ to key challenges in echo exams – how time consuming the exam is and the degree of variability that exists in the quantitative results,” Saetre said. “This package supports our vision of where we need to go with cardiovascular ultrasound: tools to support less variability and improved productivity.”
New Study Examines Short-Term Consistency of Large Language Models in Radiology
November 22nd 2024While GPT-4 demonstrated higher overall accuracy than other large language models in answering ACR Diagnostic in Training Exam multiple-choice questions, researchers noted an eight percent decrease in GPT-4’s accuracy rate from the first month to the third month of the study.
The Reading Room Podcast: Emerging Trends in the Radiology Workforce
February 11th 2022Richard Duszak, MD, and Mina Makary, MD, discuss a number of issues, ranging from demographic trends and NPRPs to physician burnout and medical student recruitment, that figure to impact the radiology workforce now and in the near future.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
Ultrasound Device Garners FDA De Novo Nod for Kidney Stone Clearance
November 14th 2024Emerging research demonstrated that the Stone Clear device, which facilitates post-lithotripsy clearance of kidney stone fragments, led to a 70 percent lower risk of relapse in comparison to observation in a control group.